STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...

A 5-year-old boy from Center City has faced rare odds since birth and now this warrior is in a real life race to rewrite his story.

UniQure said it has aligned with the FDA on components of a statistical analysis plan for a registrational trial of AMT-130.

Discover how biotechs and big pharma are developing novel treatments for high cholesterol with a range of different targets.

A new peptide-siRNA drug delivery system could revolutionise treatment for osteoarthritis by targeting pain and inflammation at the source.

In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...

The FDA rolled out its agency-wide AI tool weeks ahead of schedule, on Monday offering a look at the technology and how it ...

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

AMT-130 has been granted the FDA's Regenerative Medicine Advance Therapy (RMAT) designation and Breakthrough Therapy designation, the first therapy for Huntington's disease to receive an RMAT ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests. The treatment could also delay the need for gruelling chemotherapy, ...